Clascoterone and Trenbolone Interaction

Monitor
Mechanism-based 51% confidence

Clascoterone and Trenbolone have an interaction requiring monitoring for interaction with 51% confidence. Both Clascoterone and Trenbolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. These compounds primarily affect different organ systems.

Compound Profiles

Clascoterone

Topical Androgen Receptor Inhibitor | Acne & Hair Loss

Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).

Half-life: Short topical (local action; rapidly metabolized to cortexolone) Typical dose: Acne: 1% cream 2x/day | Hair loss: 7.5% solution once daily hair loss, skin
androgen receptorngf androgenicteratogenic
View full profile

Trenbolone

19-Nor Anabolic-Androgenic Steroid | Potent Recomposition Agent

Trenbolone binds to the androgen receptor with approximately three to five times the affinity of testosterone, making it one of the strongest known AR agonists among anabolic steroids. This exceptional binding affinity drives potent activation of AR-dependent gene transcription, resulting in dramatically enhanced nitrogen retention, protein synthesis, and satellite cell proliferation in skeletal muscle.

Half-life: ~3 days (acetate) Typical dose: 200-400 mg/week anabolic
androgen receptoraromataseigf1ngf androgenicblood pressure raisingcarcinogenic riskcardiotoxic
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Skin
low
Liver
low

Shared Safety Flags

2x 2 androgenic compounds (Clascoterone, Trenbolone). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the teratogenic safety flag (Clascoterone, Trenbolone). Monitor accordingly.

Frequently Asked Questions

Can I take Clascoterone with Trenbolone?

Yes, but with caution. Both Clascoterone and Trenbolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.

Is Clascoterone and Trenbolone safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, teratogenic. Monitor accordingly.

What are the interactions between Clascoterone and Trenbolone?

Both Clascoterone and Trenbolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time Clascoterone and Trenbolone?

Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and Trenbolone has a half-life of ~3 days (acetate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Clascoterone vs Trenbolone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.